Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5211) 5211
Newsletter (164) 164
Newspaper Article (55) 55
Magazine Article (26) 26
Dissertation (15) 15
Book Chapter (9) 9
Publication (4) 4
Conference Proceeding (2) 2
Report (2) 2
Reference (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3896) 3896
science & technology (3470) 3470
life sciences & biomedicine (3385) 3385
male (3167) 3167
female (2516) 2516
omeprazole (2252) 2252
omeprazole - administration & dosage (2215) 2215
adult (2087) 2087
biological and medical sciences (2039) 2039
medical sciences (1982) 1982
middle aged (1919) 1919
pharmacology. drug treatments (1567) 1567
omeprazole - therapeutic use (1516) 1516
gastroenterology & hepatology (1455) 1455
pharmacology & pharmacy (1400) 1400
anti-ulcer agents - administration & dosage (1242) 1242
aged (1222) 1222
2-pyridinylmethylsulfinylbenzimidazoles (1183) 1183
helicobacter infections - drug therapy (1179) 1179
omeprazole - analogs & derivatives (1141) 1141
digestive system (1107) 1107
drug therapy, combination (1017) 1017
anti-ulcer agents - therapeutic use (1016) 1016
proton pump inhibitors (1013) 1013
omeprazole - pharmacology (930) 930
helicobacter pylori (919) 919
treatment outcome (892) 892
animals (875) 875
lansoprazole (805) 805
drug administration schedule (643) 643
omeprazole - adverse effects (636) 636
amoxicillin - administration & dosage (597) 597
abridged index medicus (580) 580
rats (532) 532
double-blind method (531) 531
administration, oral (528) 528
anti-bacterial agents - administration & dosage (516) 516
dose-response relationship, drug (515) 515
clarithromycin - administration & dosage (501) 501
time factors (500) 500
adolescent (493) 493
omeprazole - pharmacokinetics (473) 473
anti-ulcer agents - pharmacology (471) 471
helicobacter pylori - drug effects (469) 469
prospective studies (469) 469
gastroesophageal reflux - drug therapy (454) 454
drug interactions (441) 441
duodenal ulcer - drug therapy (428) 428
hydrogen-ion concentration (404) 404
anti-bacterial agents - therapeutic use (360) 360
benzimidazoles - administration & dosage (352) 352
aged, 80 and over (350) 350
rabeprazole (343) 343
cross-over studies (336) 336
peptic ulcer - drug therapy (334) 334
anti-ulcer agents - adverse effects (328) 328
stomach ulcer - drug therapy (322) 322
metronidazole - administration & dosage (321) 321
gastroenterology. liver. pancreas. abdomen (319) 319
gastric mucosa - drug effects (315) 315
amoxicillin - therapeutic use (310) 310
gastric acid - metabolism (306) 306
medicine & public health (301) 301
follow-up studies (299) 299
enzyme inhibitors - administration & dosage (286) 286
clarithromycin - therapeutic use (281) 281
gastric acid - secretion (270) 270
general & internal medicine (261) 261
drug therapy (253) 253
proton pump inhibitors - administration & dosage (252) 252
pharmacokinetics (251) 251
gastrins - blood (250) 250
research (250) 250
medicine, general & internal (249) 249
gastroesophageal reflux (246) 246
benzimidazoles - therapeutic use (243) 243
gastric acidity determination (243) 243
pantoprazole (242) 242
recurrence (241) 241
area under curve (238) 238
helicobacter infections - complications (237) 237
analysis (236) 236
proton pump inhibitor (234) 234
anti-ulcer agents - pharmacokinetics (227) 227
care and treatment (227) 227
cytochrome p-450 cyp2c19 (226) 226
helicobacter infections - microbiology (222) 222
helicobacter pylori - isolation & purification (216) 216
dosage and administration (213) 213
proton pump inhibitors - therapeutic use (213) 213
ranitidine - administration & dosage (213) 213
omeprazole - blood (212) 212
young adult (210) 210
ranitidine - therapeutic use (209) 209
enzyme inhibitors - therapeutic use (207) 207
benzimidazoles - pharmacology (206) 206
gastric mucosa - pathology (205) 205
gastroenterology (203) 203
rats, sprague-dawley (203) 203
risk factors (199) 199
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5078) 5078
Japanese (163) 163
German (118) 118
Spanish (91) 91
Russian (80) 80
French (38) 38
Chinese (29) 29
Portuguese (25) 25
Italian (17) 17
Korean (14) 14
Swedish (14) 14
Norwegian (9) 9
Ukrainian (6) 6
Danish (5) 5
Polish (5) 5
Czech (4) 4
Hungarian (4) 4
Croatian (3) 3
Bulgarian (2) 2
Dutch (2) 2
Bosnian (1) 1
Finnish (1) 1
Lithuanian (1) 1
Persian (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Geneva Cocktail for Cytochrome P450 and P‐Glycoprotein Activity Assessment Using Dried Blood Spots
by Bosilkovska, M and Samer, C F and Déglon, J and Rebsamen, M and Staub, C and Dayer, P and Walder, B and Desmeules, J A and Daali, Y
Clinical pharmacology and therapeutics, ISSN 0009-9236, 09/2014, Volume 96, Issue 3, pp. 349 - 359
Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Predictive Value of Tests | Pharmaceutical Preparations - blood | Caffeine - administration & dosage | Cytochrome P-450 Enzyme Inhibitors | Dried Blood Spot Testing | Humans | Omeprazole - blood | Bupropion - blood | Midazolam - administration & dosage | Substrate Specificity | Male | Chromatography, High Pressure Liquid | ATP-Binding Cassette, Sub-Family B, Member 1 - antagonists & inhibitors | Coffee | Terfenadine - administration & dosage | Caffeine - pharmacokinetics | Feasibility Studies | Enzyme Inhibitors - administration & dosage | Young Adult | Chromatography, Reverse-Phase | Tandem Mass Spectrometry | Capsules | Spectrometry, Mass, Electrospray Ionization | Flurbiprofen - administration & dosage | Adult | Dextromethorphan - pharmacokinetics | Terfenadine - blood | ATP-Binding Cassette, Sub-Family B, Member 1 - blood | Pharmaceutical Preparations - administration & dosage | Terfenadine - pharmacokinetics | Bupropion - pharmacokinetics | Flurbiprofen - pharmacokinetics | Cytochrome P-450 Enzyme System - blood | Administration, Oral | Isoenzymes | Caffeine - blood | Omeprazole - administration & dosage | Terfenadine - analogs & derivatives | Omeprazole - pharmacokinetics | Carbonated Beverages | Midazolam - pharmacokinetics | Bupropion - administration & dosage | Dextromethorphan - blood | Flurbiprofen - blood | Phenotype | Pilot Projects | Midazolam - blood | Dextromethorphan - administration & dosage | Usage | Glycoproteins | Liquid chromatography | Research | Pharmacokinetics | Cytochrome P-450 | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text The bioavailability of bromazepam, omeprazole and paracetamol given by nasogastric feeding tube
by Podilsky, Gregory and Berger-Gryllaki, Markoulina and Testa, Bernard and Buclin, Thierry and Roulet, Michel and Pannatier, Andre
European journal of clinical pharmacology, ISSN 0031-6970, 5/2009, Volume 65, Issue 5, pp. 435 - 442
Omeprazole | Bromazepam | Paracetamol | Biomedicine | Bioavailability | Nasogastric route | Oral route | Pharmacology/Toxicology | Pharmacokinetics | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Biological and medical sciences | Pharmacology. Drug treatments | Medical sciences | Anti-Anxiety Agents - administration & dosage | Prospective Studies | Analgesics, Non-Narcotic - pharmacokinetics | Area Under Curve | Humans | Omeprazole - blood | Acetaminophen - administration & dosage | Half-Life | Biological Availability | Bromazepam - administration & dosage | Male | Metabolic Clearance Rate | Anti-Ulcer Agents - blood | Anti-Ulcer Agents - pharmacokinetics | Anti-Anxiety Agents - pharmacokinetics | Acetaminophen - blood | Bromazepam - blood | Intubation, Gastrointestinal | Female | Analgesics, Non-Narcotic - blood | Reproducibility of Results | Administration, Oral | Omeprazole - administration & dosage | Omeprazole - pharmacokinetics | Analgesics, Non-Narcotic - administration & dosage | Anti-Ulcer Agents - administration & dosage | Cross-Over Studies | Anti-Anxiety Agents - blood | Bromazepam - pharmacokinetics | Acetaminophen - pharmacokinetics | Cohort Studies | Therapeutic Equivalency | Acetaminophen | Analysis | Pharmacy | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Pharmacokinetic and Pharmacodynamic Alterations in the Roux-en-Y Gastric Bypass Recipients
by Tandra, Sweta and Chalasani, Naga and Jones, David R and Mattar, Samer and Hall, Stephen D and Vuppalanchi, Raj
Annals of surgery, ISSN 0003-4932, 08/2013, Volume 258, Issue 2, pp. 262 - 269
furosemide | oral cocktail | CYP3A | gastric bypass | drug metabolism | Life Sciences & Biomedicine | Surgery | Science & Technology | Gastric Bypass | Diuretics - pharmacokinetics | Excitatory Amino Acid Antagonists - pharmacokinetics | Humans | Middle Aged | Tolbutamide - urine | Male | Caffeine - pharmacokinetics | Midazolam - urine | Anti-Ulcer Agents - pharmacokinetics | Young Adult | Hypoglycemic Agents - administration & dosage | Aged, 80 and over | Diuretics - urine | Diuretics - administration & dosage | Hypoglycemic Agents - pharmacokinetics | Administration, Oral | Furosemide - pharmacokinetics | Omeprazole - administration & dosage | Excitatory Amino Acid Antagonists - administration & dosage | Hypoglycemic Agents - urine | Omeprazole - urine | Central Nervous System Stimulants - pharmacokinetics | Midazolam - blood | Dextromethorphan - urine | Adolescent | GABA Modulators - urine | Central Nervous System Stimulants - urine | Dextromethorphan - administration & dosage | Furosemide - administration & dosage | Tolbutamide - administration & dosage | Tolbutamide - pharmacokinetics | Caffeine - administration & dosage | Omeprazole - blood | GABA Modulators - pharmacokinetics | Midazolam - administration & dosage | Anti-Ulcer Agents - blood | Chromatography, High Pressure Liquid | Case-Control Studies | Excitatory Amino Acid Antagonists - urine | Hypoglycemic Agents - blood | Tandem Mass Spectrometry | Biotransformation | Adult | Female | Dextromethorphan - pharmacokinetics | Furosemide - urine | Caffeine - urine | Caffeine - blood | GABA Modulators - administration & dosage | GABA Modulators - blood | Omeprazole - pharmacokinetics | Anti-Ulcer Agents - urine | Midazolam - pharmacokinetics | Anti-Ulcer Agents - administration & dosage | Dextromethorphan - blood | Excitatory Amino Acid Antagonists - blood | Tolbutamide - blood | Aged | Central Nervous System Stimulants - blood | Pharmacokinetics | Central Nervous System Stimulants - administration & dosage | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial
by Malfertheiner, Peter, Prof and Bazzoli, Franco, Prof and Delchier, Jean-Charles, Prof and Celiñski, Krysztof, Prof and Giguère, Monique, PhD and Rivière, Marc, MD and Mégraud, Francis, Prof and for the Pylera Study Group and Pylera Study Grp and Pylera Study Group
The Lancet (British edition), ISSN 0140-6736, 2011, Volume 377, Issue 9769, pp. 905 - 913
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Bacterial diseases of the digestive system and abdomen | Public health. Hygiene-occupational medicine | Public health. Hygiene | General aspects | Miscellaneous | Infectious diseases | Bacterial diseases | Human bacterial diseases | Biological and medical sciences | Medical sciences | Tablets | Humans | Middle Aged | Drug Resistance, Bacterial | Male | Young Adult | Helicobacter pylori | Helicobacter Infections - drug therapy | Clarithromycin - administration & dosage | Metronidazole - adverse effects | Adult | Female | Amoxicillin - administration & dosage | Helicobacter Infections - diagnosis | Drug Therapy, Combination | Clarithromycin - adverse effects | Organometallic Compounds - adverse effects | Metronidazole - administration & dosage | Omeprazole - administration & dosage | Anti-Ulcer Agents - adverse effects | Breath Tests | Omeprazole - adverse effects | Tetracycline - adverse effects | Anti-Ulcer Agents - administration & dosage | Adolescent | Anti-Bacterial Agents - administration & dosage | Tetracycline - administration & dosage | Drug Combinations | Organometallic Compounds - administration & dosage | Omeprazole | Gastrointestinal diseases | Research | Diagnosis | Drug therapy, Combination | Drug therapy | Comparative analysis | Health aspects | Studies | Histology | Clinical medicine | Drug resistance | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Drug–drug interactions between sucroferric oxyhydroxide and losartan, furosemide, omeprazole, digoxin and warfarin in healthy subjects
by Chong, Edward and Kalia, Veena and Willsie, Sandra and Winkle, Peter
Journal of nephrology, ISSN 1121-8428, 12/2014, Volume 27, Issue 6, pp. 659 - 666
Nephrology | Phase I | Medicine & Public Health | Urology/Andrology | Hyperphosphatemia | Chronic kidney disease | Pharmacokinetics | Sucroferric oxyhydroxide | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Digoxin - adverse effects | Diuretics - pharmacokinetics | Chelating Agents - administration & dosage | Humans | Middle Aged | Half-Life | Male | Metabolic Clearance Rate | Angiotensin II Type 1 Receptor Blockers - pharmacokinetics | Warfarin - administration & dosage | Young Adult | Drug Interactions | Proton Pump Inhibitors - administration & dosage | Cardiotonic Agents - adverse effects | Diuretics - blood | Angiotensin II Type 1 Receptor Blockers - administration & dosage | Diuretics - administration & dosage | Risk Assessment | Furosemide - pharmacokinetics | Cardiotonic Agents - pharmacokinetics | Omeprazole - administration & dosage | Sucrose - adverse effects | Anticoagulants - adverse effects | Anticoagulants - blood | Cardiotonic Agents - administration & dosage | Models, Biological | Ferric Compounds - adverse effects | Losartan - administration & dosage | Diuretics - adverse effects | Furosemide - administration & dosage | Angiotensin II Type 1 Receptor Blockers - adverse effects | Anticoagulants - administration & dosage | Area Under Curve | Losartan - blood | Omeprazole - blood | Warfarin - adverse effects | Ferric Compounds - administration & dosage | Healthy Volunteers | Furosemide - adverse effects | Adult | Female | Proton Pump Inhibitors - blood | Digoxin - blood | Losartan - pharmacokinetics | Chelating Agents - adverse effects | Furosemide - blood | Sucrose - administration & dosage | Proton Pump Inhibitors - adverse effects | Drug Administration Schedule | Omeprazole - adverse effects | Omeprazole - pharmacokinetics | Models, Statistical | Digoxin - pharmacokinetics | Warfarin - pharmacokinetics | Proton Pump Inhibitors - pharmacokinetics | Digoxin - administration & dosage | Cardiotonic Agents - blood | Warfarin - blood | Losartan - adverse effects | Anticoagulants - pharmacokinetics | Angiotensin II Type 1 Receptor Blockers - blood | Drug Combinations | Index Medicus | Original
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Randomised controlled trial: susceptibility‐guided therapy versus empiric bismuth quadruple therapy for first‐line Helicobacter pylori treatment
by Chen, Qi and Long, Xiaohua and Ji, Yingjie and Liang, Xiao and Li, Dongping and Gao, Hong and Xu, Beili and Liu, Ming and Chen, Ying and Sun, Yunwei and Zhao, Yan and Xu, Gang and Song, Yanyan and Yu, Lou and Zhang, Wei and Liu, Wenzhong and Graham, David Y and Lu, Hong
Alimentary pharmacology & therapeutics, ISSN 0269-2813, 06/2019, Volume 49, Issue 11, pp. 1385 - 1394
Gastroenterology & Hepatology | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Science & Technology | Bismuth - administration & dosage | Drug Administration Schedule | Esomeprazole - administration & dosage | Humans | Metronidazole - administration & dosage | Middle Aged | Male | Treatment Outcome | Young Adult | Helicobacter pylori | Proton Pump Inhibitors - administration & dosage | Helicobacter Infections - drug therapy | Adolescent | Clarithromycin - administration & dosage | Adult | Female | Aged | Amoxicillin - administration & dosage | Drug Therapy, Combination | Anti-Bacterial Agents - administration & dosage | Levofloxacin - administration & dosage | Omeprazole | Therapy | Levofloxacin | Clarithromycin | Randomization | Amoxicillin | Bismuth | Infections | Metronidazole | Antimicrobial resistance | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Helicobacter Pylori First-Line and Rescue Treatments in the Presence of Penicillin Allergy
by Gisbert, Javier P and Gisbert, Javier P and Barrio, Jesús and Barrio, Jesús and Modolell, Inés and Modolell, Inés and Molina-Infante, Javier and Molina-Infante, Javier and Aisa, Angeles Perez and Aisa, Angeles Perez and Castro-Fernández, Manuel and Castro-Fernández, Manuel and Rodrigo, Luis and Rodrigo, Luis and Cosme, Angel and Cosme, Angel and Gisbert, Jose Luis and Gisbert, Jose Luis and Fernández-Bermejo, Miguel and Fernández-Bermejo, Miguel and Marcos, Santiago and Marcos, Santiago and Marín, Alicia C and Marín, Alicia C and McNicholl, Adrián G and McNicholl, Adrián G
Digestive diseases and sciences, ISSN 0163-2116, 2/2015, Volume 60, Issue 2, pp. 458 - 464
Biochemistry, general | Levofloxacin | Allergy | Quinolone | Oncology | Eradication | Allergic | Transplant Surgery | Medicine & Public Health | Helicobacter pylori | Hepatology | Gastroenterology | Penicillin | Bismuth | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Predictive Value of Tests | Bismuth - administration & dosage | Prospective Studies | Humans | Middle Aged | Salvage Therapy | Helicobacter pylori - drug effects | Male | Rifabutin - administration & dosage | Proton Pump Inhibitors - administration & dosage | Time Factors | Antacids - adverse effects | Helicobacter Infections - drug therapy | Clarithromycin - administration & dosage | Penicillins - adverse effects | Female | Anti-Bacterial Agents - adverse effects | Helicobacter Infections - diagnosis | Drug Therapy, Combination | Levofloxacin - administration & dosage | Drug Hypersensitivity - etiology | Proton Pump Inhibitors - adverse effects | Drug Administration Schedule | Metronidazole - administration & dosage | Omeprazole - administration & dosage | Breath Tests | Treatment Outcome | Spain | Medication Adherence | Helicobacter pylori - isolation & purification | Antacids - administration & dosage | Anti-Bacterial Agents - administration & dosage | Tetracycline - administration & dosage | Helicobacter Infections - microbiology | Urea | Antibacterial agents | Allergic reaction | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Effect of Short-Term Fasting on Systemic Cytochrome P450-Mediated Drug Metabolism in Healthy Subjects: A Randomized, Controlled, Crossover Study Using a Cocktail Approach
by Lammers, Laureen A and Achterbergh, Roos and van Schaik, Ron H. N and Romijn, Johannes A and Mathôt, Ron A. A
Clinical pharmacokinetics, ISSN 0312-5963, 10/2017, Volume 56, Issue 10, pp. 1231 - 1244
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Omeprazole - metabolism | Caffeine - administration & dosage | Humans | Warfarin - metabolism | Cytochrome P-450 Enzyme System - metabolism | Midazolam - administration & dosage | Male | Healthy Volunteers | Warfarin - administration & dosage | Young Adult | Time Factors | Adult | Metoprolol - metabolism | Fasting - metabolism | Pharmaceutical Preparations - administration & dosage | Cytochrome P-450 CYP2C9 - metabolism | Caffeine - metabolism | Administration, Oral | Omeprazole - administration & dosage | Metoprolol - administration & dosage | Cytochrome P-450 CYP1A2 - metabolism | Cross-Over Studies | Administration, Intravenous | Pharmaceutical Preparations - metabolism | Cytochrome P-450 CYP2D6 - metabolism | Midazolam - metabolism | Drug Combinations
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Differential Effects of Omeprazole and Pantoprazole on the Pharmacodynamics and Pharmacokinetics of Clopidogrel in Healthy Subjects: Randomized, Placebo-Controlled, Crossover Comparison Studies
by Angiolillo, D J and Gibson, C M and Cheng, S and Ollier, C and Nicolas, O and Bergougnan, L and Perrin, L and LaCreta, F P and Hurbin, F and Dubar, M
Clinical pharmacology and therapeutics, ISSN 0009-9236, 01/2011, Volume 89, Issue 1, pp. 65 - 74
Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Proton Pump Inhibitors - pharmacology | Ticlopidine - pharmacology | Humans | Middle Aged | Half-Life | Male | 2-Pyridinylmethylsulfinylbenzimidazoles - pharmacology | Enzyme Inhibitors - administration & dosage | Platelet Aggregation Inhibitors - blood | Young Adult | Drug Interactions | Proton Pump Inhibitors - administration & dosage | Platelet Aggregation Inhibitors - pharmacology | Adult | Female | Omeprazole - pharmacology | Platelet Aggregation - drug effects | Platelet Aggregation Inhibitors - pharmacokinetics | Ticlopidine - pharmacokinetics | Enzyme Inhibitors - adverse effects | Proton Pump Inhibitors - adverse effects | Aryl Hydrocarbon Hydroxylases - antagonists & inhibitors | Double-Blind Method | Drug Administration Schedule | 2-Pyridinylmethylsulfinylbenzimidazoles - adverse effects | Omeprazole - administration & dosage | Enzyme Inhibitors - pharmacology | Omeprazole - adverse effects |